Open Access Tolvaptan Journals
A list of Open Access Tolvaptan journals for you to publish your manuscript in
Tolvaptan is selective, competitive vasopressin receptor 2 antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone
Open access (OA) is a key part of making research shareable and reproducable. All journal articles published open access undergoe the same rigorous peer review process.
Our team made this list of Tolvaptan Open Access journals with the aim to help you to decide where to publish your Tolvaptan manuscript.
The list below includes all high-impact factor Tolvaptan journals as well as new up and comming journals where it might also be more affordable to publish.Rather than displaying just the most relevant Tolvaptan journals, we have made an in-depth list of all the open accesss Tolvaptan journals. Use our different columns — number of papers, number of citations, and relevance — to find the best Tolvaptan venue for your manuscript.
The DOAJ columns refers to the The Directory of Open Access Journals, a list of open access journals, maintained by Infrastructure Services for Open Access.
There are certain criteria a journal must meet to be indexed by DOAJ, and thus inclusion in the DOAJ index is seen by scholars as a mark of quality.
All the open access Tolvaptan journals in this list are indexed in OA.mg.
If you spot any mistakes in this table of Tolvaptan OA journals, don’t hesitate to send us an email.
Name | ISSN | DOAJ | Publisher | No. of Papers | Citations | Relevance▼ | Website |
---|